<SEC-DOCUMENT>0001437749-24-020830-index.html : 20240620
<SEC-HEADER>0001437749-24-020830.hdr.sgml : 20240620
<ACCEPTANCE-DATETIME>20240620171242
ACCESSION NUMBER:		0001437749-24-020830
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20240620
DATE AS OF CHANGE:		20240620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280363
		FILM NUMBER:		241057426

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>nby20240619_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
Document 1 - file: nby20240619_s1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_690586.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: ex_690586.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex_690762.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: ex_690762.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex_690763.htm
<DESCRIPTION>EXHIBIT FILING FEES
<TEXT>
Document 4 - file: ex_690763.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex_690586img001.jpg
<TEXT>
Document 5 - file: ex_690586img001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nby20240619_s1img001.jpg
<TEXT>
Document 6 - file: nby20240619_s1img001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>nby20240619_s1img002.jpg
<TEXT>
Document 7 - file: nby20240619_s1img002.jpg

</DOCUMENT>
</SEC-DOCUMENT>